The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...
Trevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...
Early results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...
Tezspire targets the airway epithelium, the primary source of inflammation. Credit: Emily Frost / Shutterstock. Amgen and AstraZeneca have reported complete outcomes from the registrational Phase III ...
The company plans to push ahead with its Essential3 trial programme, despite indications it will fail to meet its endpoints. Credit: Shutterstock / R Photography Background. US-based Praxis Precision ...
The trial is expected to enrol 40 subjects across 25 sites globally in the IO-108 part of the study. Credit: New Africa/Shutterstock. Immune-Onc Therapeutics has dosed the first subject in the Phase ...
The trial enrolled subjects who had not previously been treated with a janus kinase inhibitor or other biologic therapies. Credit: zorukis/Shutterstock. Nektar Therapeutics has concluded target ...
The trial involves the pancreatic cancer therapy, glufosfamide. Credit: SewCreamStudio/Shutterstock. BullFrog AI Holdings has announced a partnership agreement with ...
Current paediatric standard-of-care for galactosemia is a galactose-free diet. Image credit: Shutterstock / Photoongraphy. Nearly three months after an experimental treatment for classic galactosemia ...
The company also claims that its percutaneous approach allows it to avoid the potentially painful infections associated with the devices’ placement. Credit: Shutterstock / Super8. Neuspera Medical’s ...
The trial involved healthy volunteers who had been vaccinated previously against the Omicron XBB1.5 variant. Credit: BaLL LunLa / Shutterstock. Imunon has reported new immunogenicity and safety data ...
Teesside University is committed to developing the talent pipeline essential for biosciences growth.